How many insider declarations has Davis, Sarah Ruth filed?

Davis, Sarah Ruth has filed 2 public insider declarations with SEDI.

What is Davis, Sarah Ruth's role?

Davis, Sarah Ruth's reported role is not specified by the regulator across the filings.

Which companies does Davis, Sarah Ruth report trades for?

Davis, Sarah Ruth reports trades for 2 companies, including Apotex Health Corp..

What is Davis, Sarah Ruth's declared buy vs sell volume?

Across the available history, declared buys total 3k€ and disposals 0.

← Executives ★ Sign in to follow

DS

Davis, Sarah Ruth

OFFICER

·SEDI

Apotex Health Corp.Pet Valu Holdings Ltd.

0

Total declarations

0

Companies

€2,549

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Explore the detailed record of transactions filed by Davis, Sarah Ruth. Director active across 2 companies, notably Apotex Health Corp.. Cumulatively, 2 filings have been logged. Split: 1 buy · 0 sell. Total volume traded: €3k. History available since 15 June 2026. The latest transaction was filed on 15 June 2026 (30 - Acquisition or disposition under a purchase/ownership plan). Regulator: SEDI. All data is free.

Companies and markets linked to Davis, Sarah Ruth

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Apotex Health Corp. (CA)Pet Valu Holdings Ltd. (CA)

Declarations2 total

▲

Davis, Sarah Ruth

4 - Director of IssuerExecutives15 Jun 2026Pet Valu Holdings Ltd.

CA$4,1330SEDI ↗

219 shares@ CA$18.87Deferred Share UnitsTSXSEDI:4754570

Canonical exit: 13 Sept 2026 (T+90)

●

Davis, Sarah Ruth

4 - Director of IssuerExecutives9 Jun 2026Apotex Health Corp.

11SEDI ↗

Common SharesTSXSEDI:4737004

2 of 2 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

DS

Davis, Sarah Ruth

OFFICER

·SEDI

Apotex Health Corp.Pet Valu Holdings Ltd.

0

Total declarations

0

Companies

€2,549

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Explore the detailed record of transactions filed by Davis, Sarah Ruth. Director active across 2 companies, notably Apotex Health Corp.. Cumulatively, 2 filings have been logged. Split: 1 buy · 0 sell. Total volume traded: €3k. History available since 15 June 2026. The latest transaction was filed on 15 June 2026 (30 - Acquisition or disposition under a purchase/ownership plan). Regulator: SEDI. All data is free.